Small number of HTLV-1-positive cells frequently remains during complete remission after allogeneic hematopoietic stem cell transplantation that are heterogeneous in origin among cases with adult T-cell leukemia/ lymphoma

Leukemia

Volumn 21, Issue 6, 2007, Pages 1212-1217

  Yamasaki, R ^a   Miyazaki, Y ^a   Moriuchi, Y ^b   Tsutsumi, C ^a   Fukushima, T ^a   Yoshida, S ^c   Taguchi, J ^b   Inoue, Y ^a   Matsuo, E ^a   Imaizumi, Y ^a   Imanishi, D ^a   Fujimoto, T ^a   Tsushima, H ^a   Honda, S ^a   Hata, T ^a   Tsukasaki, K ^a   Tomonaga, M ^a  

^a NAGASAKI UNIVERSITY GRADUATE SCHOOL OF BIOMEDICAL SCIENCES   (Japan)

^b Sasebo Shiritsu Sogo Hospital   (Japan)

^c NATIONAL HOSPITAL ORGANIZATION NAGASAKI MEDICAL CENTER   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

BUSULFAN; CYCLOPHOSPHAMIDE; CYTARABINE; ETOPOSIDE; FLUDARABINE; HUMAN T CELL LEUKEMIA VIRUS ANTIBODY; MELPHALAN; THYMOCYTE ANTIBODY;

ACUTE GRAFT VERSUS HOST DISEASE; ADULT; ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; ARTICLE; CANCER CONTROL; CANCER REGRESSION; CANCER SURVIVOR; CHRONIC GRAFT VERSUS HOST DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GRAFT RECIPIENT; HUMAN; HUMAN CELL; HUMAN T CELL LEUKEMIA VIRUS 1; LEUKEMIA CELL; LYMPHOMA CELL; MALE; MINIMAL RESIDUAL DISEASE; PERIPHERAL BLOOD MONONUCLEAR CELL; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROVIRUS; REDUCED INTENSITY CONDITIONING; T CELL LEUKEMIA; T CELL LYMPHOMA; VIRUS GENOME; VIRUS LOAD; WHOLE BODY RADIATION;

EID: 34249716881     PISSN: 08876924     EISSN: 14765551     Source Type: Journal    
DOI: 10.1038/sj.leu.2404678     Document Type: Article

References (19)

1. Poiesz BJ, Ruscetti FW, Gazdar AF, Bunn PA, Minna JD, Gallo RC. Detection and isolation of type C retrovirus particles from fresh and cultured lymphocytes of a patients with cutaneous T-cell lymphoma. Proc Natl Acad Sci USA 1980; 77: 7419-7451.
2. Hinuma Y, Nagata K, Hanaoka M, Nakai M, Matsumoto T, Kinoshita KI et al. Adult T-cell leukemia: Antigen in an ATL cell line and detection of antibodies to the antigen in human sera. Proc Natl Acad Sci USA 1981; 78: 6476-6480.
3. Uchiyama T. Human T cell leukemia virus type I (HTLV-I) and human diseases. Annu Rev Immunol 1997; 15: 15-37.
4. Yoshida M, Seiki M, Yamaguchi K, Takatsuki K. Monoclonal integration of human T-cell leukemia provirus in all primary tumors of adult T-cell leukemia suggests causative role of human T-cell leukemia virus in the disease. Proc Natl Acad Sci USA 1984; 81: 2534-2537.
5. Abott MA, Poiesz BJ, Byrne BC, Kwok S, Sninsky JJ, Ehrlich GD. Enzymatic gene amplification: Qualitative and quantitative methods for detecting proviral DNA amplified in vitro. J Infect Dis 1998; 158: 1158-1169.
6. Kawase KI, Katamine S, Moriuchi R, Miyamoto T, Kubota K, Igarashi H et al. Maternal transmission of HTLV-1 other than through breast milk: Discrepancy between the polymerase chain reaction positivity of cord blood samples for HTLV-1 and the subsequent seropositivity of individuals. Jpn J Cancer Res 1992; 83: 968-977.
7. Yamada Y, Tomonaga M. The current status of therapy for adult T-cell leukaemia-lymphoma in Japan. Leuk Lymphoma 2003; 44: 611-618.
8. Tsukasaki K, Maeda T, Arimura. K, Taguchi J, Fukushima T, Miyazaki Y et al. Poor outcome of autologous stem cell transplantation for adult T cell leukemia/lymphoma: A case report and review of the literature. Bone Marrow Transplant 1999; 23: 87-89.
9. Kami M, Hamaki T, Miyakoshi S, Musashige N, Kanda Y, Tanosaki Y et al. Allogeneic haematopoietic stem cell transplantation for the treatment of adult T-cell leukaemia/lymphoma. Br J Haematol 2003; 120: 304-309.
10. Utsunomiya A, Miyazaki Y, Takatsuka Y, Hanada S, Uozumi K, Yashiki S et al. Improved outcome of adult T cell leukemia/lymphoma with allogeneic hematopoietic stem cell transplantation. Bone Marrow Transplant 2001; 27: 15-20.
11. Fukushima T, Miyazaki Y, Honda S, Kawano F, Moriuchi Y, Masuda M et al. Allogeneic hematopoietic stem cell transplantation provides sustained long-term survival for patients with adult T-cell leukemia/ lymphoma. Leukemia 2005; 19: 829-834.
12. Shimoyama M, members of the Lymphoma Study Group. Diagnostic criteria and classification of clinical subtypes of adult T-cell leukaemia/ lymphoma. Br J Haematol 1991; 79: 428-437.
13. Kamihira S, Dateki N, Sugahara K, Yamada Y, Tomonaga M, Maeda T et al. Real-time polymerase chain reaction for quantification of HTLV-1 proviral load: Application for analyzing aberrant integration of the proviral DNA in adult T-cell leukemia. Int J Hematol 2000; 72 79-84.
14. Takemoto S, Matsuoka M, Yamaguchi K, Takatsuki K. A novel diagnostic method of adult T-cell leukemia: Monoclonal integration of human T-cell lymphotropic virus type I provirus DNA detected by inverse polymerase chain reaction. Blood 1994; 84: 3080-3085.
15. Hata T, Fujimoto T, Tsushima H, Murata K, Tsukasaki K, Atogami S et al. Multi-clonal expansion of unique human T-lymphotropic virus type-I-infected T cells with high growth potential in response to interleukin-2 in prodoromal phase of adult T cell leukemia. Leukemia 1999; 13: 215-221.
16. Hishizawa M, Imada K, Ishikawa T, Uchiyama T. Kinetics of proviral DNA, soluble interleukin-2 receptor level and tax expression in patients with adult T-cell leukemia receiving allogeneic stem cell transplantation. Leukemia 2004; 18: 167-169.
17. Ljungman P, Lawler M, Asjo B, Bogdanovic G, Karlsson K, Malm C et al. Infection of donor lymphocytes with human T lymphotrophic virus type 1 (HTLV-1) following allogeneic bone marrow transplantation for HTLV-I positive adult T-cell leukaemia. Br J Haematol 1994; 88: 403-405.
18. Kawa K, Nishiuchi R, Okamura T, Igarashi H. Eradication of human T-lymphotropic virus type 1 by allogeneic bone-marrow transplantation. Lancet 1998; 352: 1034-1035.
19. Harashima N, Kurihara K, Utsunomiya A, Tanosaki R, Hanabuchi S, Masuda M et al. Graft-versus-Tax response in adult T-cell leukemia patients after hematopoietic stem cell transplantation. Cancer Res 2004; 64: 391-399.